The effect of Nigella sativa oil and metformin on male seminal parameters and testosterone in Wistar rats exposed to an obesogenic diet.
File(s)Leisegang et al - Biomed Pharmacother 2021.pdf (1.83 MB)
Published version
Author(s)
Leisegang, Kristian
Almaghrawi, Walid
Henkel, Ralf
Type
Journal Article
Abstract
Obesity is a significant global health and socio-economic challenge, and considered an important risk factor for poor health outcomes including male reproductive dysfunction and infertility. As excess adiposity causes testicular dysfunction and infertility, novel therapeutic strategies require investigation. Nigella sativa (Ns) seed oil and metformin have both demonstrated a potential positive effect on obesity, although both remain poorly investigated in male fertility. Therefore, this study aimed to determine the effect of Ns oil and metformin on total body weight (TBW), mitochondrial membrane potential (MMP), serum testosterone and semen parameters in an obese animal model. Wistar rats (n = 54) were divided into six groups: normal chow (NC), high sugar diet (HSD) only, HSD and saline, HSD and metformin (75 mg/Kg/day), HSD and Ns (200 mg/Kg/day) (NS200), HSD and Ns (400 mg/Kg/day) (NS400). Intervention was force fed for the last 8 weeks of the 14 weeks dietary exposures. Results showed that the HSD increased TBW (P = 0.001) and reduced sperm concentration (P = 0.013) and progressive motility (P = 0.009) compared to the NC group. Metformin, NS200 and NS400 improved TBW (P = 0.035, P = 0.006 and P = 0.005, respectively) and testosterone (P < 0.001) compared to the HSD saline group, where metformin and NS400 improved sperm concentration (P < 0.001 and P = 0.049, respectively) and MMP (P < 0.001). There were no changes in sperm motility and viability for all experimental exposures, although NS400 (P = 0.047) negatively affected sperm viability. Metformin and Ns may be novel treatment options in obesity-induced infertility, although a potential negative impact on viability is cautioned for high dose Ns. These results warrant further investigation of Ns and Metformin for the management of obese infertile males.
Date Issued
2021-01
Date Acceptance
2020-11-28
Citation
Biomedicine and Pharmacotherapy, 2021, 133, pp.1-9
ISSN
0753-3322
Publisher
Elsevier
Start Page
1
End Page
9
Journal / Book Title
Biomedicine and Pharmacotherapy
Volume
133
Copyright Statement
© 2020 The Author(s). Published by Elsevier Masson SAS. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/33378981
PII: S0753-3322(20)31278-6
Subjects
Animals
Anti-Obesity Agents
Biomarkers
Disease Models, Animal
Fertility
Fertility Agents, Male
Infertility, Male
Male
Membrane Potential, Mitochondrial
Metformin
Obesity
Plant Oils
Rats, Wistar
Sperm Count
Sperm Motility
Spermatozoa
Testosterone
Metformin
Nigella sativa
Obesity
Semen analysis
Testosterone
Publication Status
Published
Coverage Spatial
France
Date Publish Online
2020-12-08